SI-BONE, Inc. (SIBN)

SI-BONE, Inc. is a medical device company that specializes in minimally invasive surgical implants to treat certain sacroiliac joint disorders. Founded in 2008 and headquartered in Santa Clara, California, the company is well-regarded for its innovative sacroiliac joint fusion system, known as iFuse. This system helps patients who suffer from lower back pain due to sacroiliac joint dysfunction. The company's current CEO is Laura Francis, who has been leading SI-BONE's efforts to expand both its product offerings and global reach. In 2022, SI-BONE reported a revenue of over $100 million, indicating solid growth and a strong presence in the healthcare industry. Committed to improving patient outcomes, SI-BONE continues to invest in research and development to advance surgical solutions for musculoskeletal disorders.